| Ticker | CSTL |
|---|---|
| ISIN | US14843C1053 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; Decision...
El precio actual de Castle Biosciences, Inc. (CSTL) es de 24,46 , con una variación del 3,25%.
Castle Biosciences, Inc. opera en el sector Healthcare, industria Medical - Diagnostics & Research.